While most pharma companies have exited the antibiotics area, Japanese drugmaker Shionogi has stuck with it and has just expanded its pipeline with a deal to buy US biotech Qpex Biopharma.

Venture capital firm Kineticos Life Sciences has launched a new biotech to take forward a class of antibiotics forged in the labs of Harvard University. Kineticos has already set up an accelerator ...

The facility, situated in Biotech Park ... Officials discovered that additional antibiotics, including Amoxicillin 1000 mg + Clavulanic Acid 200 mg, Ampicillin + Sulbactam 2000 mg + 1000 mg ...

An undated photo from the Centers for Disease Control and Prevention shows a strain of Candida auris cultured in a petri dish. A CDC paper published in 2023 revealed that cases of the dangerous ...